AtriCure Inc. Executive Compensation & Stock Awards Revealed
Ticker: ATRC · Form: DEF 14A · Filed: Apr 7, 2025 · CIK: 1323885
Sentiment: neutral
Topics: executive-compensation, stock-awards, proxy-statement
TL;DR
AtriCure's 2025 DEF 14A shows exec comp details & stock awards for 2024. Shareholders watch dilution.
AI Summary
AtriCure, Inc. filed its DEF 14A on April 7, 2025, detailing executive compensation and stock awards for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted, outstanding, and unvested, with specific figures for the number of employees and the valuation of these awards. This document is crucial for understanding how the company incentivizes its key personnel and the potential dilution from stock-based compensation.
Why It Matters
This filing provides insight into AtriCure's executive compensation structure and the value of stock awards, which can impact shareholder value and employee motivation.
Risk Assessment
Risk Level: medium — DEF 14A filings can reveal significant information about executive compensation and stock dilution, which are key factors for investors.
Key Numbers
- 3841 — SIC Code (Indicates AtriCure operates in the Surgical & Medical Instruments & Apparatus industry.)
Key Players & Entities
- AtriCure, Inc. (company) — Filer of the DEF 14A
- 0001323885-25-000037 (filing_id) — Accession Number for the filing
- 20250407 (date) — Filing Date
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the total number of equity awards granted to employees in the fiscal year ending December 31, 2024?
The filing indicates that for the fiscal year 2024, there were equity awards granted to employees, but the exact total number is not explicitly stated in the provided snippet. The snippet refers to 'EqtyAwrdsInSummryCompstnTblForAplblYrMember' and 'PeoMember' for 2024.
What is the reported value of outstanding and unvested equity awards as of December 31, 2024?
The filing references 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember' for 2024, suggesting this data is present, but the specific dollar value is not detailed in the provided text.
Who are the named executive officers whose compensation is detailed in this filing?
The provided text snippet does not list the named executive officers. A full review of the DEF 14A document would be required to identify them.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for their annual meeting, and it contains detailed information about executive compensation, board of directors, and other corporate governance matters.
When was AtriCure, Inc. incorporated?
AtriCure, Inc. was incorporated in Delaware (DE), as indicated by the 'STATE OF INCORPORATION: DE' field in the filing.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 7, 2025 regarding AtriCure, Inc. (ATRC).